LM Funding America Announces December 2025 Production and Operational Update

(NASDAQ:LMFA), – Bitcoin treasury as of December 31, 2025 valued at $31.4 million or $1.46 per share1 TAMPA, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month […]

UniFirst Announces Financial Results for the First Quarter of Fiscal 2026

(NYSE:UNF), WILMINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (“UniFirst” or the “Company”) today reported results for its fiscal 2026 first quarter ended November 29, 2025. First Quarter 2026 Consolidated Results Consolidated revenues increased 2.7% to $621.3 million compared to $604.9 million in the first quarter of fiscal 2025, driven by

Signing Day Sports Provides Transaction Update on Proposed Business Combination with BlockchAIn Digital Infrastructure

(NYSE MKT:SGN), SCOTTSDALE, AZ, Jan. 07, 2026 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform dedicated to improving the recruiting process for high school athletes and college coaches, today provided an update on its previously announced proposed

Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac Energetics in Cardiometabolic Disease

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) In IMPROVE-DiCE, treatment with ninerafaxstat was associated with improvements in cardiac energetics, systolic reserve function, exercise capacity, and heart failure symptoms BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Imbria Pharmaceuticals,

Vocodia Announces Commitment Letter to Acquire a Majority of Privacy Pal LLC; Tech Industry Veteran Jason Melo to Serve as CEO

(PinkSheets:VHAI),(Pinksheets:VHAI), BOCA RATON, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — Vocodia Holdings Corp (OTC: VHAI) (“Vocodia” or the “Company”), a pioneer in AI-driven customer engagement solutions, today announced it has entered into a commitment letter to acquire 51% of Privacy Pal LLC., the developer of AI privacy solution PrivacyPal. PrivacyPal AI runs in your web

Apollo Backs $5.4 Billion Valor and xAI Data Center Compute Infrastructure Transaction with $3.5 Billion Capital Solution

(NYSE:APO), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates (the “Apollo Funds”) have led a $3.5 billion capital solution for Valor Compute Infrastructure L.P. (“VCI”), a fund managed by Valor Equity Partners (“Valor”), to support its $5.4 billion acquisition and lease of data center compute

4DMT Provides Company Update and Anticipated Development Milestones for 2026

(NASDAQ:FDMT), Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as of January 6, 2026 4D-150 PRISM wet AMD 2-year Phase 2b data expected mid-2026 4D-150 DME global Phase 3 trial initiation expected Q3

Gray Media Names Kristy Santiago as General Manager of KFVS in Cape Girardeau, Missouri

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. has named Kristy Santiago as the next General Manager of KFVS (CBS and CW) in Cape Girardeau, Missouri and WQWQ-LD (Telemundo) in Paducah, Kentucky. Kristy brings decades of experience in television station management and sales operations. Throughout her career, she has overseen operations for

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH(R) (VP-102) for the Treatment of Common Warts

(NasdaqGM:VRCA), – Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market opportunity- – Verrica has global rights to YCANTH for all indications in all territories outside of Japan – WEST CHESTER, Pa., Jan. 07, 2026

Rocky Mountain Chocolate Factory Schedules Fiscal Third Quarter 2026 Conference Call for January 14, 2026 at 9:00 A.M. ET

(NASDAQ:RMCF), DURANGO, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), America's Chocolatier(TM) and a leading franchiser of a premium chocolate and confectionary retail store concept, will host a conference call on Wednesday, January 14, 2026 at 9:00 a.m. Eastern time to discuss its fiscal

Scroll to Top